These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 7848543)
1. Comparative tolerability profiles of oral antidiabetic agents. Krentz AJ; Ferner RE; Bailey CJ Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543 [TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
3. Antihyperglycaemic agents. Drug interactions of clinical importance. Scheen AJ; Lefèbvre PJ Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency. Harrower AD Clin Pharmacokinet; 1996 Aug; 31(2):111-9. PubMed ID: 8853933 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic optimisation of oral hypoglycaemic therapy. Marchetti P; Giannarelli R; di Carlo A; Navalesi R Clin Pharmacokinet; 1991 Oct; 21(4):308-17. PubMed ID: 1760902 [TBL] [Abstract][Full Text] [Related]
6. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus. Jennings PE Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853 [TBL] [Abstract][Full Text] [Related]
8. Management of antidiabetic medications in overdose. Spiller HA Drug Saf; 1998 Nov; 19(5):411-24. PubMed ID: 9825953 [TBL] [Abstract][Full Text] [Related]
12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
13. Metformin and the sulphonylureas: the comparative risk. Campbell IW Horm Metab Res Suppl; 1985; 15():105-11. PubMed ID: 3935560 [TBL] [Abstract][Full Text] [Related]
14. Comparative tolerability of sulphonylureas in diabetes mellitus. Harrower AD Drug Saf; 2000 Apr; 22(4):313-20. PubMed ID: 10789825 [TBL] [Abstract][Full Text] [Related]
15. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides. Berger W Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878 [TBL] [Abstract][Full Text] [Related]
16. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes. Scheen AJ; Castillo MJ; Lefèbvre PJ Acta Clin Belg; 1993; 48(4):259-68. PubMed ID: 8212978 [TBL] [Abstract][Full Text] [Related]
17. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? Nattrass M; Lauritzen T Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S21-31. PubMed ID: 11063281 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced disorders of glucose metabolism. Mechanisms and management. Chan JC; Cockram CS; Critchley JA Drug Saf; 1996 Aug; 15(2):135-57. PubMed ID: 8884164 [TBL] [Abstract][Full Text] [Related]